Flavoxate (hydro<wbr>chloride)

Flavoxate (hydrochloride)

CAT N°: 19096
Price:

From 66.00 56.10

Flavoxate is an inhibitor of L-type calcium channels and an antimuscarinic agent.{30978} It induces relaxation of potassium-precontracted isolated human urinary bladder detrusor muscle (IC50 = 2 µM) and reduces contractions induced by the acetylcholine receptor agonist carbachol (carbamoylcholine; Item No. 14486) or calcium in isolated rat detrusor strips.{30978,57774} Microinjection of flavoxate (0.68 µg/animal) into the oral pontine reticular nucleus inhibits reflex micturition in decerebrated cats, and intravenous or intracerebroventricular administration reduces isovolumetric rhythmic bladder contractions in rats.{57774} Formulations containing flavoxate have previously been used in the treatment of frequent or urgent urination, increased nocturnal urination, bladder pain, and urinary incontinence.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester, monohydrochloride
  • Correlated keywords
    • 15301-69-6 DW 61 DW61 genurin NSC114649 patricin peflate piperidinoethyl-3-methylflavone-8-carboxylate rec7/0040 rec70040 70040 rec spasmal spasuret urispas Cav1.2 Cav12 Cav-1.2 Cav-12 L-type Ltype calcium muscarinic acetylcholine overactive bladder muscle relaxant bladderon anticholinergic anti-cholinergic urinary spasm
  • Product Overview:
    Flavoxate is an inhibitor of L-type calcium channels and an antimuscarinic agent.{30978} It induces relaxation of potassium-precontracted isolated human urinary bladder detrusor muscle (IC50 = 2 µM) and reduces contractions induced by the acetylcholine receptor agonist carbachol (carbamoylcholine; Item No. 14486) or calcium in isolated rat detrusor strips.{30978,57774} Microinjection of flavoxate (0.68 µg/animal) into the oral pontine reticular nucleus inhibits reflex micturition in decerebrated cats, and intravenous or intracerebroventricular administration reduces isovolumetric rhythmic bladder contractions in rats.{57774} Formulations containing flavoxate have previously been used in the treatment of frequent or urgent urination, increased nocturnal urination, bladder pain, and urinary incontinence.

We also advise you